key: cord-0744680-ha5voupo
authors: Pessoa, Natália Lima; Bentes, Aline Almeida; de Carvalho, Andrea Lucchesi; de Souza Silva, Thaís Bárbara; Alves, Pedro Augusto; de Sousa Reis, Erik Vinicius; Rodrigues, Tayse Andrade; Kroon, Erna Geessien; Campos, Marco Antônio
title: Case report: hepatitis in a child infected with SARS-CoV-2 presenting toll-like receptor 7 Gln11Leu single nucleotide polymorphism
date: 2021-09-05
journal: Virol J
DOI: 10.1186/s12985-021-01656-3
sha: d9bcd2078a6e4ef2681c99fda76c4e06b50b38e6
doc_id: 744680
cord_uid: ha5voupo

BACKGROUND: Covid-19 has the respiratory tract as the main target of infection, and patients present mainly dyspnea, pneumonia, dry cough, and fever. Nevertheless, organs outside the respiratory tract had been reported in recent studies, including the gastrointestinal tract and liver. The host innate immune system recognizes pathogen-associated molecular patterns (PAMPs) through their pattern recognition receptor (PRRs). Toll-like receptor 7 (TLR-7) is a pattern recognition receptor recognizing ssRNA (SARS-CoV-2 is an ssRNA). Polymorphisms are characterized by two or more alternative forms of a distinct phenotype in the same population. Polymorphisms in tlrs genes can negatively influence the immune response to infectious diseases. There are several references in the literature to non-synonymous single nucleotide (rs) polymorphisms related to several genes. Some of them are important for the innate immunity, as rs 179008 (tlr-7), rs3775291 (tlr3), rs8177374 (tir domain-containing adaptor protein, tirap), rs1024611 (monocyte chemoattractant protein-1, mcp-1) and rs61942233 (2′-5′-oligoadenylate synthase-3, oas-3). CASE PRESENTATION: We identified a 5-year-old-male child with gastrointestinal symptoms and fever presenting acholic stool and jaundice, who was positive for SARS-CoV-2 IgM, IgA, and IgG and presenting the Gln11Leu rs 179008 in tlr-7. The child presented high levels of aspartate aminotransferase, alanine aminotransferase, bilirubin, C-reactive protein, D-dimer, gamma-glutamyl transferase, alkaline phosphatase, and was negative for serological tests for hepatitis A, B, C, E, HIV 1 and 2, herpes virus, cytomegalovirus, Epstein–Barr virus, and negative for RTqPCR for Influenza A and B, RSV and SARS-CoV-2. We also investigated other SNPs in the tlr-3 (rs3775291), tirap (rs8177374), mcp-1 (rs1024611), and oas-3 (rs61942233) genes, and no mutation was detected. After an interview with the child's caregivers, any possible accidental ingestion of drugs or hepatotoxic substances was ruled out. CONCLUSION: To our knowledge, this is the first report of a SARS-CoV-2 caused hepatitis in a male child that has the tlr-7 Gln11Leu rs 179008, which could impair an efficient initial immune response. The knowledge of the patient's immune deficiency could improve the treatment to correct this deficiency with specific medications.

Coronavirus disease 2019 (COVID-19) is a significant global public health problem. The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), a Open Access *Correspondence: marco.campos@fiocruz.br † Natália Lima Pessoa and Aline Almeida Bentes have contributed equally to this work 2 Imunologia de Doenças Virais, Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG, Brazil Full list of author information is available at the end of the article single-stranded RNA (ssRNA) virus, has the respiratory tract as the main target of infection, and patients present mainly dyspnea, pneumonia, dry cough, and fever [1] . Nevertheless, the involvement of organs outside the respiratory tract had been reported in recent studies, including the gastrointestinal tract and liver [2] [3] [4] . Liver damage of varying degrees was present in 58-78% of patients [3] .

The host immune response to SARS-CoV-2 infection plays an important role in the severity of the disease [5] . It is responsible for recognizing pathogen-associated molecular patterns (PAMPs) through their pattern recognition receptor (PRRs). Toll-like receptor 7 (TLR-7) is a PRR that recognizes ssRNA [6] . Polymorphisms are characterized by two or more alternative forms of a distinct phenotype in the same population, and polymorphisms in TLRs can negatively influence the immune response to infectious diseases [7] . There are several references in the literature to non-synonymous single nucleotide (rs) polymorphisms related to several genes (https:// www. genec ards. org/). Some of them are important for the innate immunity, as rs179008 (tlr-7), rs3775291 (tlr3), rs8177374 (tir domain-containing adaptor protein, tirap), rs1024611 (monocyte chemoattractant protein-1, mcp-1) and rs61942233 (2′-5′-oligoadenylate synthase-3, oas-3) (https:// www. genec ards. org/).

Unique loss-of-function variants in X chromosomal tlr-7 were identified in four young men with severe COVID-19 [8] , and rs179008 in tlr-7 gene have been related with increased risk to progress to advanced liver disease in hepatitis C virus (HCV) infection [9] . In the present case report, we identified a male child with the tlr-7 gene Gln-11Leu single nucleotide polymorphism (rs 179008) with hepatitis and positive serological SARS-CoV-2 test. We also investigated other SNPs in the tlr-3, tirap, MCP-1, and oas-3 genes, and no mutation was detected.

A 5-years-old male child started with fever, odynophagia, diarrhea, abdominal pain, and vomiting on August 19, 2020. On the 23rd, still with fever, he developed acholic stool and jaundice. The child was hospitalized after medical evaluation and tests that detected hepatitis. The patient has asthma and extensively used beclomethasone spray at a low dose of 100 mcg/day. He had no other diseases, and this was his first hospital stay. On the child's vaccination card, there was one dose of hepatitis A and three doses of hepatitis B. After an interview with the child's caregivers, any possible accidental ingestion of drugs or hepatotoxic substances was also ruled out.

The child remained hospitalized for supportive treatment and tests for 4 days, being discharged with improvement in fever, vomiting, and abdominal pain. However, the child was admitted again 4 days later because he had fever, tiredness, and edema in the lower limbs. He was discharged after 3 days. There was no bleeding or hemodynamic failure at any time. The patient received only supportive treatment.

To investigate the possible cause of this hepatitis in this patient, serological tests for viral hepatitis (hepatitis A, B, C, E, HIV-1 and -2, EBV, and CMV), and tests to evaluate possible autoimmune hepatitis, Wilson's disease, and alpha1-antitrypsin deficiency, were performed (Table 1) . All these tests were negative. The child shows a positive IgG for EBV and CMV. As the boy had one positive epidemiology for Covid-19 associated with fever, odynophagia and changes in inflammatory markers, coagulation profile, and D-dimer, a serological test was requested and was positive for IgM, IgG, and IgA for SARS-CoV-2, with the kits Biolisa-CoV-2 IgM, Biolisa-CoV-2 IgG, and Biolisa-CoV2 IgA (Bioclin, Quibasa, Brazil), respectively. The RT-qPCR for SARS-CoV-2 was performed from the nasopharynx and oropharynx 6 days after symptoms and was negative ( Table 1 ). An echocardiogram was performed due to the possibility of multisystem inflammatory syndrome associated with covid-19, but the exam did not show changes in cardiac function or coronary dilation. After hospital discharge, the patient continues to be followed up on an outpatient clinic with a pediatric gastroenterology team, but without other clinical manifestations. The patient underwent cholangioresonance examination in January 2021, but the examination did not show any changes. At this time, the antinuclear antibody was also not reactive. Other diagnostic tests performed for differential diagnoses such as Wilson's disease, alpha-1-antitrypsin deficiency, autoimmune hepatitis, and primary sclerosing cholangitis were negative.

SNPs were selected based on previously reported associations with higher susceptibility of the host to other viral infections and with tlr genes, and proteins from the TLR activated cascade. Thereby, SNP rs179008 in the tlr-7 gene, rs3775291 in the tlr-3 gene, rs8177374 in the tirap gene, rs1024611 in the mcp-1 gene, and rs61942233 in the oas-3 gene were tested. The primers used were: 5′-AGA GAG GCA GCA AAT GGG AA-3′ and 5′-TAG GAA ACC ATC TAG CCC CA-3′ for tlr-7, 5′-GCG AAC TTT GAC AAA TGA AACA -3′ and 5′-CCC AAC CAA GAG AAA GCA TC-3′ for tlr-3, 5′-GGT GCA AGT ACC AGA TGC T-3′ and 5′-CAA CGC ATG ACA GCT TCT TT-3′ for tirap, 5′-CTT CTC TCA CGC CAG CAC -3′ and 5′-ACA GTA AAC ACA GGG AAG GT-3′ for mcp-1 and 5′-GCT GCT TCA GCC AGT TCA -3′ and 5′-GTC AGT GAG AAG CTC AGC A-3′ for oas-3. To detect SNPs, genomic DNA was extracted from peripheral blood, amplified by polymerase chain reaction (PCR), and sequenced. The genotype was confirmed by aligning the resulted sequence with the reference sequences from GenBank in the software Sequence Scanner 2.0 (Applied Biosystems), and novoSNP (Department of Molecular Genetics-VIB and University of Antwerp).

No base change was detected on rs3775291 (tlr-3), rs8177374 (TIRAP), rs1024611 (mcp-1), and rs61942233 (oas-3), being a normal homozygote for these genes. A base change (A > T) was detected on rs179008 (tlr-7) SNP, being a mutated SNP, which causes an amino acid change (Q to L).

The procedures were in accord with the ethical standards of the responsible committee on human experimentation from Instituto René Rachou, Fundação Oswaldo Cruz [CAAE 37207920.6.0000.5091] and with the Helsinki Declaration (1964, amended most recently in 2008) of the World Medical Association and the patient's responsible written consent was obtained. 

At the beginning of the Covid-19 pandemic, few infections and severe cases in young adults and almost none in children were reported [1] . On February 8, 2021, Lachassinne et al. reported that the incidence of SARS-CoV-2 infection in children was still low [10] . We wondered why some of the children could be infected and developed a severe Covid-19. Liu and Hill [5] reported that primary immunodeficient patients could be more susceptible to severe infections, posing a high risk to Covid-19. Deficiency in antiviral innate immune signaling (TLRs, TIRAP) [5] or chemokines (MCP-1) essential to call the appropriated immune defense cells or in interferon-induced molecules (OAS-3) would be some targets to find the answer to this question. Initially, we addressed our efforts to verify if there were non-synonymous SNPs in DNA that codify these proteins, using the blood of children who needed to be admitted to the hospital.

Although Covid-19 involves mainly the respiratory tract, there are some representative numbers of articles in the literature showing that several organs, including the liver and gastrointestinal tract, are also affected by SARS-CoV-2 [2] [3] [4] .

Here we reported hepatitis, with gastrointestinal symptoms and fever in a 5-year-old male child, who was negative for hepatitis A, B, C, E, cytomegalovirus, Epstein Barr, syphilis, HIV, herpes, influenza, and respiratory syncytial virus. Additionally, the boy was positive for SARS-CoV-2 IgM, IgA, and IgG and presented one rs179008 in tlr-7. However, although immune tests were positive against SARS-CoV-2, a nasal swab collected 6 days after initial symptoms was RTq-PCR negative. Lack of detection of viral RNA 6 days after the first symptoms could be due to partial elimination of the virus confirmed by the presence of antibodies, or even the collection having been made traditionally only in the nasopharynx and oropharynx, since the child had no respiratory manifestations. Wang et al. 2021 [11] tested different clinical samples and detected SARS-CoV-2 in blood and feces. Kucirka et al. 2020 [12] also raised the question about the predictive value of the RTqPCR, which varies with time from exposure and symptom onset, predicting a reduction of 67% in the positivity on the fourth day.

Hepatitis provoked by SARS-CoV-2 could be associated with the impaired innate immunity against the virus caused by the polymorphism in tlr-7 rs179008. The same SNP was reported by Fakhir et al. as being one of the causes of the impaired immune response during HCV infection [9] . Azar et al. (2020) reported patients infected with HIV-1, which presented the rs179008, produced lower quantities of TLR-7, resulting in lower production of IFN-1, with consequent higher viral load [13] .

To our knowledge, this is the first report of a SARS-CoV-2 caused hepatitis in a male child that has the rs179008 tlr-7, which could impair an efficient initial immune response. The knowledge of the patient's immune deficiency could improve the treatment to correct this deficiency with specific medications. 

Ready to submit your research Ready to submit your research ? Choose BMC and benefit from:

? Choose BMC and benefit from:

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Liver injury in COVID-19: management and challenges

Liver injury during highly pathogenic human coronavirus infections

Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review

Role of host immune and inflammatory responses in COVID-19. Cases with underlying primary immunodeficiency: a review

Innate immune recognition of viral infection

Toll-like receptor polymorphism in host immune response to infectious diseases: a review

Presence of genetic variants among young men with severe COVID-19

Genetic variations in toll-like receptors 7 and 8 modulate natural hepatitis C outcomes and liver disease progression

SARS-CoV-2 transmission among children and staff in daycare centers during a nationwide lockdown in France: a cross-sectional, multicenter, seroprevalence study

Detection of SARS-CoV-2 in different types of clinical specimens

Variation in false-negative rate of reverse transcriptase polymerase chain reactionbased SARS-CoV-2 tests by time since exposure

TLR7 dosage polymorphism shapes interferogenesis and HIV-1 acute viremia in women

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

The authors acknowledge the work and contribution of all the health providers from Hospital João Paulo II, PHEMIG, and the program for technological development in tools for health-PDTIS-FIOCRUZ for the use of its facilities.

Authors' contributions NLP, AAB, EGK, PAA, and MAC conceived and designed the experiments. NLP, TBSS, EVSR, and TAR performed the experiments. NLP, AAB, ALC, EGK, and MAC analyzed the data. MAC and EGK contributed reagents, materials, and analysis tools. AAB and ALC, did attendance and medical assistance to and blood collecting from the children. NLP, AAB, EGK, and MAC wrote the paper. All authors read and approved the final manuscript. 

All data and information are available without restriction and included in the manuscript.

Ethics approval and consent to participate This project was approved by the Ethical Committee of Institute René Rachou, Fiocruz, CAAE 37207920.6.0000.5091. The patient's responsible written permission was obtained.

The patient's responsible written permission was obtained.